Pacifico Biolabs
Develops mycelium fermentation processes to produce alternative protein, scaling production in disused brewery tanks across Europe.
Overview
Pacifico Biolabs is building a mycelium fermentation platform for alternative protein, positioning itself as a rival to Quorn. The company is focused on scaling production in Europe by using disused brewery tanks as fermentation infrastructure. The approach targets the alternative-protein market with a differentiated manufacturing strategy that repurposes existing brewing assets. Pacifico Biolabs raised a €7M Series A in May 2026 to support its European scale-up.
Funding History
Quorn rival Pacifico Biolabs raises €7M Series A to scale mycelium fermentation in Europe’s disused brewery tanks
Frequently Asked Questions
- How much has Pacifico Biolabs raised in total?
- Pacifico Biolabs has raised a total of $7M across 1 funding round.
- Who are Pacifico Biolabs's investors?
- Pacifico Biolabs's investors include Undisclosed.
- What does Pacifico Biolabs do?
- Pacifico Biolabs is building a mycelium fermentation platform for alternative protein, positioning itself as a rival to Quorn. The company is focused on scaling production in Europe by using disused brewery tanks as fermentation infrastructure. The approach targets the alternative-protein market with a differentiated manufacturing strategy that repurposes existing brewing assets. Pacifico Biolabs raised a €7M Series A in May 2026 to support its European scale-up.
- Where is Pacifico Biolabs headquartered?
- Pacifico Biolabs is headquartered in Europe.
Investors
Related Insights
The definitive guide to AI startup funding in 2026 — from pre-seed through IPO, covering valuation mechanics, timelines, investor expectations, and how AI companies differ from traditional tech startups.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.